MOUNT YALE INVESTMENT ADVISORS, LLC – Neurocrine Biosciences, Inc. Transaction History
MOUNT YALE INVESTMENT ADVISORS, LLC portfolio value:
$848,000
portfolio value
MOUNT YALE INVESTMENT ADVISORS, LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.62% | -215 shares | 49K | $106.21 | 7.98K |
| Q2 2022 | share | Decrease | -5.57% | -484 shares | -15K | $97.48 | 8.19K |
| Q1 2022 | share | Increase | 0.00% | 8.68K shares | 814K | $93.75 | 8.68K |
| Q4 2021 | share | Decrease | -100.00% | -6.53K shares | -626K | $84.63 | 0 |
| Q3 2021 | share | Increase | +0.74% | 48 shares | -5K | $95.91 | 6.53K |
| Q2 2021 | share | Increase | +1.95% | 124 shares | 12K | $97.32 | 6.48K |
| Q1 2021 | share | Increase | 0.00% | 6.36K shares | 619K | $97.25 | 6.36K |
| Q4 2020 | share | Decrease | -100.00% | -5.08K shares | -488K | $95.85 | 0 |
| Q3 2020 | share | Increase | 0.00% | 5.08K shares | 488K | $96.16 | 5.08K |